Loading...
Forward Pharma A/S
FWPAY•PNK
HealthcareBiotechnology
$300.00
$-100.50(-25.09%)
Forward Pharma A/S (FWPAY) Stock Overview
Explore Forward Pharma A/S’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for FWPAYStats details for FWPAY are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for FWPAYAnalyst Recommendations details for FWPAY are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.
CEO
Dr. Claus Bo Søndergaard Svendsen M.D., Ph.D.
Employees
4
Headquarters
Oestergade 24A, Copenhagen
Founded
2014